General Catalyst
VC Fund
Cambridge, United States
General Catalyst is an investment firm that supports businesses at every stage, from seed to growth. It focuses on fostering resilience and advancing applied AI through its investments. The firm collaborates with entrepreneurs to provide capital and strategic guidance, enabling innovation across industries such as healthcare, fintech, and consumer technology.
- Total investments:
- 2289
- Last investment:
- Lead investor:
- 46%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries General Catalyst invests in
Stages General Catalyst invests in
Countries General Catalyst invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 60 contacts → | |||
Round size
- Seed
- $1.6M–$18M
- Series A
- $6.7M–$75M
- Series B
- $14M–$123M
Investment Focus
Industry
- Software 275 (12%)
- Artificial Intelligence 220 (10%)
- Health Care 153 (7%)
- Information Technology 121 (5%)
- SaaS 81 (4%)
Stage
- Seed 408 (18%)
- Series A 379 (17%)
- Series B 280 (12%)
- Series C 170 (7%)
- Series D 97 (4%)
Country
- United States 751 (33%)
- India 39 (2%)
- United Kingdom 39 (2%)
- Germany 17 (1%)
- Canada 11 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christopher Kauffman
Principal
|
Principal | Total investments: 11 | Find email | |
|
Erin Schaefer
COO
|
COO | Total investments: 1 | Find email | |
|
Genevieve Kinney
Principal
|
Principal | Total investments: 9 | Find email | |
|
Jeremy Goldstein
Partner
|
Partner | Total investments: 10 | Find email | |
|
Jim Baum
General Catalyst
|
General Catalyst | Total investments: 11 | Find email | |
| See all 60 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Oratomic develops neutral-atom quantum hardware and architectures for fault-tolerant quantum computing. The company focuses on utility-scale quantum computers that use light and atoms to implement ultra-efficient quantum error correction. Its work targets applications ranging from scientific discovery to new approaches in artificial intelligenceand complex simulation. Oratomic combines expertise in quantum error correction, neutral-atom platforms, optical engineering, and machine learning. The organization aims to make fully fault-tolerant quantum computing practical for real-world use cases. | $475M / Series B / Oct 08, 2026 | ||
| General Intuition is a frontier research lab focused on teaching machines to learn and adapt through play, aiming to build artificial intelligence that can perceive, anticipate, and improvise in real-world dynamics, with gaming as a central domain for testing and innovation. | $220M / Venture - Series Unknown / Sep 29, 2026 | ||
| Proximal builds AI training data and environments to improve software engineering agents and autonomous coding systems. | $15M / Seed / Sep 29, 2026 | ||
| Sol a company focused on building tools to power team collaboration and collective productivity. | $4M / Seed / Sep 22, 2026 | ||
| Heidi Health is a healthtech company that develops an AI medical scribe platform that automates clinical documentation and related tasks. | $240M / Debt Financing / Sep 22, 2026 | ||
| Curelink is a health-tech platform that connects doctors to patients via WhatsApp. | $4.6M / Series A / Sep 19, 2026 | ||
|
Skalar
|
Skalar provides alternative financing for technology companies seeking capital for customer acquisition and sales and marketing activities. | Debt Financing / Sep 17, 2026 | |
| Integral provides a digital platform for businesses covering accounting, payroll, tax compliance, and financial reporting. | $20.8M / Series A / Sep 16, 2026 | ||
| Complir is a compliance platform tailored for the retail sector, assisting businesses in managing regulations and ensuring product compliance throughout the design and delivery process. It consolidates product data to ensure regulatory adherence and improve transparency across the supply chain. The platform helps retailers maintain standards andstay informed about regulatory updates by automating reporting and simplifying data management. Complir supports retailers in improving compliance and operational efficiency in their product offerings.https://www.complir.io/ | $11M / Seed / Sep 16, 2026 | ||
| Evvy is a developer of at-home vaginal microbiome tests to close the gender health gap and improve female health. It uses metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports. | $40M / Series B / Sep 15, 2026 | ||
| See all 2289 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does General Catalyst invest in?
General Catalyst invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 2,289 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is General Catalyst's check size?
General Catalyst typically joins rounds of $1.6M–$18M at Seed, $6.7M–$75M at Series A and $14M–$123M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds General Catalyst participates in.
How do I contact General Catalyst?
Public channels for General Catalyst include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at General Catalyst?
The team at General Catalyst includes Christopher Kauffman (Principal), Erin Schaefer (COO) and Genevieve Kinney (Principal), among 60 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!